ANTIBIOTIC RESISTANCE POSES A PROFOUND GLOBAL THREAT TO HUMAN HEALTH


>10 MILLION PEOPLE COULD DIE FROM ANTIBIOTIC-RESISTANT INFECTIONS BY 2050 GLOBALLY1


The DxM Trio solution has a proven track record of accurate organism identification and antimicrobial susceptibility testing in the laboratory. Together, this integrated solution of technologies streamlines processes to enhance efficiency and take strides in antibiotic stewardship.


› Combat emerging resistance with accurate detection › Improve laboratory efficiency with a reliable instrument that offers award-winning system performance2 › Reduce ancillary testing and lower costs with the DxM Trio


› Fewest clinically significant limitations of any automated identification and antimicrobial susceptibility testing (ID/AST) system


See how your laboratory can benefit from the DxM Trio solution. Learn more at www.beckmancoulter.com/dxmtrio


References


1 UN.org. UN, global health agencies sound alarm on drug-resistant infections; new recommendations to reduce ‘staggering number’ of future deaths. April 29, 2019 retrieved from https://news.un.org/en/story/2019/04/1037471


2 ServiceTrak™ Clinical Executive Summary Report for ID/AST Systems, 2019, 2018 and 2017


© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.


For Beckman Coulter’s worldwide office locations and phone numbers, please visit www.beckmancoulter.com/contact AD-284004


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63